Acute myocardial infarction following COVID-19 vaccination: a cause or a coincidence?
Автор: Elheet A.A., Farrag M.H., Elkeliei M.M., Alabdali A.M.
Журнал: Cardiometry @cardiometry
Рубрика: Case report
Статья в выпуске: 22, 2022 года.
Бесплатный доступ
Background. Acute Myocardial Infarction (AMI) is a fatal condition with a subsequent variety of complications. Recently, COVID-19 vaccine has become an essential precaution to avoid infection. However, it is uncommon for AMI to manifest as a result of the COVID-19 vaccination. Methods. Thirty-two years old man, previously healthy, come to the emergency department with a four-hour history of chest discomfort after Covishield (AstraZeneca) vaccination. He was neither hypertensive, diabetic, or smoker and lacked any other typical risk factors for cardiovascular disease. Results. This case describes an adverse response to the COVID-19 vaccination that has the potential to be life-threatening. He had received his first dose of the Covishield vaccination five days prior. Extensive anterior STEMI was diagnosed post-cardiac arrest. He had primary percutaneous coronary intervention (PCI) to recanalize an occluded proximal LAD. Conclusions. Additional screenings for young individuals should be considered before administering the COVID-19 (AstraZeneca) vaccine as a preventive step if reports of significant adverse events in older adults continue.
Covid-19, acute myocardial infarction, stemi, astrazeneca, vaccination
Короткий адрес: https://sciup.org/148324414
IDR: 148324414 | DOI: 10.18137/cardiometry.2022.22.143146
Список литературы Acute myocardial infarction following COVID-19 vaccination: a cause or a coincidence?
- Voysey M, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARSCoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021; 9;397(10269):99-111.
- DOI: 10.1016/S0140-6736(20)32661-1
- Fryar CD, Chen TC, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2012.
- Yazdanyar, A., & Newman, A. B. (2009). The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clinics in geriatric medicine, 25(4), 563.
- DOI: 10.1016/j.cger.2009.07.007
- Wise, Jacqui. "Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots". (2021).
- DOI: 10.1136/bmj.n699
- Chatterjee S, Ojha UK, Vardhan B, Tiwari A. Myocardial infarction after COVID-19 vaccination-casual or causal?. Diabetes & metabolic syndrome. 2021;15(3):1055.
- DOI: 10.1016/j.dsx.2021.04.006
- Greinacher, Andreas, Thomas Thiele, Theodore E. Warkentin, Karin Weisser, Paul Kyrle, and Sabine Eichinger. "A prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia following coronavirus-19 vaccination". (2021).
- DOI: 10.21203/rs.3.rs-362354/v2
- Boivin, Zachary, and Jennifer Martin. "Untimely myocardial infarction or COVID-19 vaccine side effect". Cureus 13, no. 3 (2021).
- DOI: 10.7759/cureus.13651
- Kounis, Nicholas G., Andreas Mazarakis, Grigorios Tsigkas, Sotiris Giannopoulos, and John Goudevenos. "Kounis syndrome: a new twist on an old disease". Future Cardiology 7, no. 6 (2011): 805-824.
- DOI: 10.2217/fca.11.63 EDN: PMYUXZ
- Kounis, Nicholas G., et al. "Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations". Vaccines 9, no. 3 (2021): 221.
- DOI: 10.3390/vaccines9030221 EDN: QZTRKY